SCHEMBL1978556

SCHEMBL1978556

CC(C)[C@H](N)CN(C(=O)O)C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.33
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GRIK1 P39086 1/20 0.31
GABRP O00591 2/20 0.30
GABRD O14764 2/20 0.30
GABRA1 P14867 2/20 0.30
GABRB1 P18505 2/20 0.30
GABRG2 P18507 2/20 0.30
GABRB3 P28472 2/20 0.30
GABRA5 P31644 2/20 0.30
GABRA3 P34903 2/20 0.30
GABRA2 P47869 2/20 0.30
GABRB2 P47870 2/20 0.30
GABRA4 P48169 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2716369 1.00 SLC7A5 (0.33) SLC7A5SLC1A3SLC1A2SLC1A1MEN1
SCHEMBL203296 0.83 GABRP (0.37) SLC7A5SLC1A3SLC1A2SLC1A1MEN1
SCHEMBL1248340 0.83 GABRP (0.37) SLC7A5SLC1A3SLC1A2SLC1A1MEN1
SCHEMBL2717315 0.83 GPR88 (0.35) GPR88DPP4
SCHEMBL15910752 0.82 GPR88 (0.35) GPR88
SCHEMBL1025811 0.81 MEN1 (0.33) MEN1HTTKMT2AL3MBTL1GRIK1
Hydrochloric Acid SCHEMBL4854700 0.79 MEN1 (0.33) MEN1HTTKMT2AL3MBTL1GRIK1
SCHEMBL15910556 0.77 SLC7A5 (0.41) SLC7A5SLC1A3SLC1A2SLC1A1MAPT
SCHEMBL15910554 0.77 SLC7A5 (0.41) SLC7A5SLC1A3SLC1A2SLC1A1MAPT
SCHEMBL13731404 0.77 MEN1 (0.33) MEN1HTTKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336122-A1 1-pyrimidinyl- or 1-pyridinyl-2-amino benzimidazole derivatives and related compounds as inhibitors of protein kinases for the treatment of cancer Vertex Pharmaceuticals Incorporated (US) 2011-06-22 EP disclosed